Delphinus Medical Technologies

Delphinus Medical Technologies develops, commercializes, sells, and provides breast cancer screening solutions for hospitals and imaging clinics in the United States and internationally. It has developed SoftVue, a 3D X-ray tomographic ultrasound imaging and risk assessment device that examines female breasts for benign or malignant masses, assesses breast cancer risk, diagnoses breast conditions, and monitors treatment.